# Chemotherapy With Low-Dose Radiation for Pediatric Hodgkin Lymphoma

> **NCT00352027** · PHASE2 · COMPLETED · sponsor: **St. Jude Children's Research Hospital** · enrollment: 81 (actual)

## Conditions studied

- Hodgkin's Lymphoma

## Interventions

- **DRUG:** Adriamycin®
- **DRUG:** Vinblastine
- **DRUG:** Nitrogen Mustard
- **DRUG:** Cyclophosphamide
- **DRUG:** Vincristine
- **DRUG:** Bleomycin
- **DRUG:** Etoposide
- **DRUG:** Prednisone
- **BIOLOGICAL:** G-CSF
- **PROCEDURE:** Radiotherapy

## Key facts

- **NCT ID:** NCT00352027
- **Lead sponsor:** St. Jude Children's Research Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-07-20
- **Primary completion:** 2015-05
- **Final completion:** 2022-11-15
- **Target enrollment:** 81 (ACTUAL)
- **Last updated:** 2023-09-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00352027

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00352027, "Chemotherapy With Low-Dose Radiation for Pediatric Hodgkin Lymphoma". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT00352027. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*